FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and OncLive's FDA Approval Report: The Regulatory Rundown for March 2025 OncLive New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, FDA OKs Tezspire for Severe Asthma Respiratory Therapy